Javascript must be enabled to continue!
The support of healthcare workers suffering from COVID 19
View through CrossRef
IntroductionThe COVID-19 pandemic has focused attention on the challenges and risks faced by frontline healthcare workers (HCW).ObjectivesTo describe the quality of management of HCW affected by the COVID-19.MethodsThis is a cross-sectional study enrolling all HCW of Farhat Hached Academic hospital who had been affected by COVID-19 during the period from september to December 2020.ResultsDuring the study period, 267 HCW were affected with a mean age of 42.3 ±10 years and a ratio-sex of 0.25. The most represented category was nurses (33.3%) followed by technicians (26.1%). Gynecology department had the highest number of affected HCW (14.4%).The majority of participants (97.4%) reported a medical care. Twelve HCW (4.5%) were hospitalized with an average length of hospital stay of 7.55 ± 6.12 days. The average length of sick leave was 18.68 ± 10.99 days. During the lockdown, 38.6% of HCW took care of their children without any external help. All of the HCW were supported by phone calls from colleagues in 88.4% of cases, the hierarchy in 67.4% of cases, occupational medicine in 60.3% of cases.ConclusionsThe impact of COVID 19 is greater in HCW than in the general population. The affected staff should have a multidimensional management to avoid post covid sequelae in both physical and mental levels.DisclosureNo significant relationships.
Royal College of Psychiatrists
Title: The support of healthcare workers suffering from COVID 19
Description:
IntroductionThe COVID-19 pandemic has focused attention on the challenges and risks faced by frontline healthcare workers (HCW).
ObjectivesTo describe the quality of management of HCW affected by the COVID-19.
MethodsThis is a cross-sectional study enrolling all HCW of Farhat Hached Academic hospital who had been affected by COVID-19 during the period from september to December 2020.
ResultsDuring the study period, 267 HCW were affected with a mean age of 42.
3 ±10 years and a ratio-sex of 0.
25.
The most represented category was nurses (33.
3%) followed by technicians (26.
1%).
Gynecology department had the highest number of affected HCW (14.
4%).
The majority of participants (97.
4%) reported a medical care.
Twelve HCW (4.
5%) were hospitalized with an average length of hospital stay of 7.
55 ± 6.
12 days.
The average length of sick leave was 18.
68 ± 10.
99 days.
During the lockdown, 38.
6% of HCW took care of their children without any external help.
All of the HCW were supported by phone calls from colleagues in 88.
4% of cases, the hierarchy in 67.
4% of cases, occupational medicine in 60.
3% of cases.
ConclusionsThe impact of COVID 19 is greater in HCW than in the general population.
The affected staff should have a multidimensional management to avoid post covid sequelae in both physical and mental levels.
DisclosureNo significant relationships.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
Abstract
Background
Given the increasing prevalence of non-albicans Candida species, including C. glabrata and C. auris, which h...
Burden of the Beast
Burden of the Beast
Introduction
Throughout the COVID-19 pandemic, and its fluctuating waves of infections and the emergence of new variants, Indigenous populations in Australia and worldwide have re...
MENTAL HEALTH OF MEDICAL WORKERS DURING COVID-19 PANDEMIC: A LITERATURE REVIEW
MENTAL HEALTH OF MEDICAL WORKERS DURING COVID-19 PANDEMIC: A LITERATURE REVIEW
Background. Medical workers at hospitals who were directly involved in the diagnosis, treatment, and care of Covid-19 infected patients were at high risk of developing mental distr...
Perceptions of Telemedicine and Rural Healthcare Access in a Developing Country: A Case Study of Bayelsa State, Nigeria
Perceptions of Telemedicine and Rural Healthcare Access in a Developing Country: A Case Study of Bayelsa State, Nigeria
Abstract
Introduction
Telemedicine is the remote delivery of healthcare services using information and communication technologies and has gained global recognition as a solution to...

